These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1262787)

  • 1. Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminase.
    Ballet JJ; Insel R; Merler E; Rosen FS
    J Exp Med; 1976 May; 143(5):1271-6. PubMed ID: 1262787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adenosine deaminase in lymphocyte proliferation.
    Hovi T; Smyth JF; Allison AC; Williams SC
    Clin Exp Immunol; 1976 Mar; 23(3):395-403. PubMed ID: 133008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
    Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
    [No Abstract]   [Full Text] [Related]  

  • 5. Tight-binding inhibitors--III. A new approach for the determination of competition between tight-binding inhibitors and substrates--inhibition of adenosine deaminase by coformycin.
    Cha S
    Biochem Pharmacol; 1976 Dec; 25(24):2695-702. PubMed ID: 1008893
    [No Abstract]   [Full Text] [Related]  

  • 6. Activated T lymphocytes resist the toxic effects of the adenosine deaminase inhibitor, 2-deoxycoformycin.
    Kotb M; Veit BC
    Cell Immunol; 1982 Sep; 72(1):64-76. PubMed ID: 6983389
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin.
    Cha S; Agarwal RP; Parks RE
    Biochem Pharmacol; 1975 Dec; 24(23):2187-97. PubMed ID: 1212267
    [No Abstract]   [Full Text] [Related]  

  • 9. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
    Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
    Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the inhibition of adenosine deaminase.
    Montgomery JA; Thomas HJ; Zell AL; Einsphar HM; Bugg CE
    J Med Chem; 1985 Nov; 28(11):1751-3. PubMed ID: 4068002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine and guanosine metabolism during phytohemagglutinin induced transformation of human lymphocytes.
    Snyder FF; Mendelsohn J; Seegmiller JE
    Adv Exp Med Biol; 1977; 76A():441-7. PubMed ID: 404852
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on inhibition of adenosine deaminase by isocoformycin in vitro and in vivo.
    Shimazaki M; Kumada Y; Takeuchi T; Umezawa H; Watanabe K
    J Antibiot (Tokyo); 1979 Jun; 32(6):654-8. PubMed ID: 468739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS; Hershfield MS
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
    Agarwal RP; Crabtree GW; Parks RE; Nelson JA; Keightley R; Parkman R; Rosen FS; Stern RC; Polmar SH
    J Clin Invest; 1976 Apr; 57(4):1025-35. PubMed ID: 947948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of ADA inhibition on B cell differentiation in the rat.
    Barton RW
    Adv Exp Med Biol; 1986; 195 Pt A():525-9. PubMed ID: 3524140
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase.
    Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):236-52. PubMed ID: 7103613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM; Belch A; Henderson JF
    Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of adenosine deaminase leads to enhanced antibody responses in the mouse.
    Nicholson JK; Gordon DS; McDougal JS
    Cell Immunol; 1983 Jul; 79(2):320-33. PubMed ID: 6347398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypoxia on the guinea-pig myocardium following inhibition of adenosine deaminase by coformycin.
    Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):287-94. PubMed ID: 6476984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes.
    Gruber HE; Cohen AH; Firestein GS; Redelman D; Bluestein HG
    Adv Exp Med Biol; 1986; 195 Pt A():503-7. PubMed ID: 3487921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.